SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-160739
Filing Date
2020-06-04
Accepted
2020-06-04 16:25:33
Documents
6
Period of Report
2020-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d938640d8k.htm 8-K 24737
2 EX-1.1 d938640dex11.htm EX-1.1 248594
3 EX-5.1 d938640dex51.htm EX-5.1 7101
4 EX-99.1 d938640dex991.htm EX-99.1 8713
5 EX-99.2 d938640dex992.htm EX-99.2 9018
6 GRAPHIC g938640g63f96.jpg GRAPHIC 3659
  Complete submission text file 0001193125-20-160739.txt   304478
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 20943239
SIC: 2836 Biological Products, (No Diagnostic Substances)